| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5842035 | Life Sciences | 2014 | 5 Pages |
Abstract
These results suggest that GLP-1(9-36) binds and has functional activity in the vasculature but these actions may be via a pathway that is distinct from the classical GLP-1 receptor and insulin secretagogue actions.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rhoda E. Kuc, Janet J. Maguire, Keith Siew, Sheena Patel, David R. Derksen, V. Margaret Jackson, Kevin M. O'Shaughnessey, Anthony P. Davenport,
![First Page Preview: Characterization of [125I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta Characterization of [125I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta](/preview/png/5842035.png)